Syngene: Your trusted CRO/CDMO across Small Molecules & Biologics
Syngene International Ltd. is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. Syngene's more than 6000 scientists offer both skills and the capacity to deliver great science, robust data security, and quality manufacturing, at speed, to improve time-to-market and lower the cost of innovation.
With a combination of dedicated research facilities for Amgen, Baxter, and Bristol-Myers Squibb as well as 2.2 Mn sq. ft of specialist discovery, development and manufacturing facilities, Syngene works with biotech companies pursuing leading-edge science as well as multinationals, including GSK, Zoetis and Merck KGaA. For more details, visit www.syngeneintl.com.
Our Integrated & End-to-End Services
Small Molecules:
Discovery: Chemistry, Biology, Safety Assessment, Computational & Data Sciences
Development: Chemical Development, Formulation Development, Analytical Development, Clinical Development
Manufacturing: Commercial manufacturing
Biologics:
Discovery: Molecular Biology, Protein Sciences, Cell line Development and Analysis, Antibody Generation.
Development & Manufacturing: Development and Manufacturing Services, Analytical Characterization and Quality Control, Viral Testing and Clearance, Bioanalytical Laboratory Services.
SynVent Integrated Drug Discovery:
SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. SynVent Integrated Drug Discovery (IDD) services are designed to provide the most effective and efficient means to conduct target validation, translational interrogation, therapeutic discovery, and preclinical development for our clients.
Executing End-to-End (E2E) discovery programs in collaboration with or on behalf of clients, SynVent IDD delivers exponential value through co-localization of world-class scientific teams across the discovery continuum, adhering to R&D timescales that are benchmarked to industry gold standards.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals.
Syngene’s unique business model allows us to offer R&D services that are flexible and are designed to suit our client’s needs. Starting with a single service (component play), our client engagement gradually leads to an expanded scope of services (cluster play) and eventually into an integrated play, where we engage across multiple platforms, including setting up Dedicated Centers.
Our Assurance of Quality:
Syngene delivers its services based on the highest quality management principles including standards / guidelines mentioned below:
GMP as per Schedule – M of Drugs and Cosmetics Act (India)
Read how Syngene's partnership with a leading Biotech company working in the field of cancer therapy grew from one small pilot project to over 100 FTEs today.
One of the largest Stability facilities in Asia, Syngene supports both small and large molecules from early development to CMC filing and commercialization.
Read how Syngene's partnership with a leading Biotech company working in the field of cancer therapy grew from one small pilot project to over 100 FTEs today.
One of the largest Stability facilities in Asia, Syngene supports both small and large molecules from early development to CMC filing and commercialization.
